Millennium Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Millennium Management’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52,500	Closed	-$447K	–	7604
2021 Q3	$447K	Buy	52,500 +12,500	+31%	+$177K	﹤0.01%	5458
2021 Q2	$656K	Buy	+40,000	New	+$808K	﹤0.01%	5060
2021 Q1	–	Sell	-10,000	Closed	-$309K	–	6649
2020 Q4	$309K	Buy	+10,000	New	+$253K	﹤0.01%	4529

Millennium Management's TCRR Position: Q2 2023 in Review

Millennium Management sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 31,683 shares — an estimated $48K sold.

Millennium Management first reported a position in TCRR in Q1 2019 and held it in 16 quarters. The position peaked at $15M in Q4 2020. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

Millennium Management reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 31,683 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $48K.
Millennium Management first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2019 and held it in 16 quarters.
Millennium Management's TCR2 Therapeutics Inc. Common Stock position peaked at $15M in Q4 2020.
0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.